Effectiveness of the Immunofecal Occult Blood Test for Colorectal Cancer Screening in a Large Population
Guaiac tests are the most widely used tests to detect colorectal cancer (CRC). However, their sensitivity is relatively low and results may be affected by various factors. Immunofecal occult blood test (IFOBT) is specific for human hemoglobin and does not require dietary restrictions.
The aim of this study was to evaluate the effectiveness of IFOBT for the screening of precancerous lesions and CRC.
From July 2006 to June 2007, IFOBT was performed on 5,919 adults who received periodic health examinations in our hospital. The positive cases were examined by colonoscopy and a double-contrast barium enema. Diagnosis was confirmed by histopathological analysis.
Positive IFOBT was detected in 314 of 5,919 cases (5.30%). Further examinations were made in 264 IFOBT-positive cases. Of these, 116 cases with colorectal cancer (16 cases) or precancerous lesions (94 cases with colorectal adenomatous polyps and 6 cases with active ulcerative colitis) were detected. The total detection rate of CRC and precancerous lesions was 43.94% (116/264). TNM classification of 16 CRC cases was as follows: TNM I in eight cases (50.00%), TNM II in seven cases (43.75%) and TNM III in one case (6.25%), indicating IFOBT can detect CRC in the early stages.
Regular IFOBT can detect precancerous lesions and CRC in early stages and can thus reduce mortality from CRC.
KeywordsImmunofecal occult blood test Lower gastrointestinal bleeding Colorectal cancer Screen
Supported by a grant from the Shanghai Leading Academic Discipline Project (No. Y0205 to Zhi-Zheng Ge).
The authors declare that they have no competing interests.
- 9.Labianca R, Beretta GD, Mosconi S, et al. Colorectal cancer: screening. Ann Oncol. 2005;16(Suppl 2: ii):127–132.Google Scholar
- 16.Yan HY, Ge ZZ. Research status of fecal occult blood test in the early diagnosis of colorectal cancer. Chin J Gastroenterol. 2006;11(6):376–378.Google Scholar
- 24.Mizutani S, Fumitani M, Kaneshiro E, et al. Fundamental evaluation of fully automated fecal occult blood analyzer “OC-SENSORμ”. J Med Pharm Sci. 2002;47(5):769–773.Google Scholar
- 25.Noboru G, Michiko F, Keiko I, et al. Basic study of OC-SENSOR μ, a compact fully automated immunochemistry analyzer for fecal occult blood tests. J Clin Lab Inst Reag. 2002;25(1):57–62.Google Scholar
- 30.U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Am Fam Physician. 2002;66(12):2287–2290.Google Scholar